Cumberland Pharmaceuticals said today it has reached an agreement with Korean-based pharmaceutical company DB Pharm Korea to commercialize its ibuprofen drug Caldolor in South Korea. Go here to read about a similar deal for the drug in Australia and New Zealand and here for more recent news from the company. Cumberland's stock (Ticker: CPIX) was trading up about 2 percent on the news.